| Aptamer ID | Aptamer descriptor | Target chemistry | Target name | Affinity | Binding Conditions/Buffer | PubMed ID |
|---|---|---|---|---|---|---|
| Apta_1139 | A04T.2 | Molecule | Warfarin | 1492 nM | 20 mM Tris-HCl, 10 mM (NH4)2SO4, 10 mM KCl | 30085205 |
| Aptamer Sequence: | AATAGGGTAAAAAAAAAAAGTTGGTCCTATG |
| The optimal secondary structure in dot-bracket notation: | .((((((.................)))))). |
| The centroid secondary structure in dot-bracket notation: | .((((((.................)))))). |
| Type | Detail | Type | Detail |
|---|---|---|---|
| Aptamer ID | Apta_1139 | Description | A04T.2 |
| Aptamer chemistry | DNA | Length | 31 nt |
| GC content | 29.0% | Molecular weight | 9,648.29 Da |
| Molarity of 1 μg/μl solution | 103.65 μM | Number of G-quadruplexes | No QGRS found |
| G-Score | N/A | Function | Targeted binding |
| Sequence | AATAGGGTAAAAAAAAAAAGTTGGTCCTATG | ||
| Applications | Binding to targets | ||
| Type | Detail | Type | Detail |
|---|---|---|---|
| PubChem ID | 54678486 | Molecular name | Warfarin |
| Molecular formula | C19H16O4 | Molecular weight | 308.3 |
| IUPAC name | 4-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-2-one | InChIKey | PJVWKTKQMONHTI-UHFFFAOYSA-N |
| LogP | 3.61 | Topological polar surface area | 67.51 |
| Hydrogen bond acceptor | 4 | Hydrogen bond donor | 1 |
Synonym(s): warfarin; 81-81-2; Coumadin; Coumafene; Prothromadin; Coumafen; Zoocoumarin; Vampirinip II; Coumarins; Coumefene; Panwarfin; Warfarine; Brumolin; Dethmor; Dethnel; Kumader; Kypfarin; Maveran; Solfarin; Kumadu; Rosex; Athrombine-K; Frass-Ratron; Mar-Frin; Rattentraenke; Rattunal; Rodafarin; Temus W; Warfarat; Kumatox; Ratorex; Ratron; Vampirinip iii; D-Con; Rats-no-more; Tox-hid; Ratten-Koederrohr; Rat-Gard; Rat-Kill; Rat-Trol; Rat-Mix; Rat-Ola; Ro-Deth; Coumaphene; Rat-a-way; Rat & mice bait; Ratoxin; Martin's mar-frin; Rat-B-gon; Maag Rattentod Cum; Warfarin plus; Rodex blox; CO-Rax; Fasco fascrat powder; Liqua-tox; Mouse pak; Place-pax; Twin light rat away; Warfarin Q; Dicusat E; Ratron G; Eastern states duocide; Compound 42; 4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one; Ratox; Cov-R-Tox; rac-Warfarin; Rodafarin C; Rough & ready mouse mix; WARF compound 42; Rat-o-cide #2; Latka 42; Arab Rat Death; Spray-trol brand roden-trol; Warf 42; 200 coumarin; Rattenstreupulver Neu Schacht; Coumaphen; Warficide; Sorexa plus; 2H-1-Benzopyran-2-one, 4-hydroxy-3-(3-oxo-1-phenylbutyl)-; Arab rat deth; Rodex; 4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one; Rattenstreupulver new schacht; Athrombin-K; W.A.R.F. 42; 4-Hydroxy-3-(3-oxo-1-phenylbutyl)coumarin; Rcra waste number P001; Sakarat; Sewarin; Waran; 3-(1'-Phenyl-2'-acetylethyl)-4-hydroxycoumarin; 2-hydroxy-3-(3-oxo-1-phenylbutyl)-4h-chromen-4-one; 4-Hydroxy-3-(3-oxo-1-fenyl-butyl) cumarine; 4-Hydroxy-3-(3-oxo-1-phenyl-butyl)-cumarin; 4OH-Coumarin deriv.; RAX; 1-(4'-Hydroxy-3'-coumarinyl)-1-phenyl-3-butanone; Rat-o-cide No. 2; 3-(alpha-Acetonylbenzyl)-4-hydroxycoumarin; 4-Idrossi-3-(3-oxo-1-fenil-butil)-cumarine; DL-3-(alpha-Acetonylbenzyl)-4-hydroxycoumarin; 4-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-2-one; (Phenyl-1 acetyl-2 ethyl) 3-hydroxy-4 coumarine; 3-(alpha-Phenyl-beta-acetylethyl)-4-hydroxycoumarin; CHEMBL1464; 951658-59-6; 3-(.alpha.-Acetonylbenzyl)-4-hydroxycoumarin; CHEBI:87732; C19H16O4; NSC59813; Rcr grey squirrel killer concentrate; 3-(Acetonylbenzyl)-4-hydroxycoumarin; 3-(alpha-Phenyl-beta-acetylaethyl)-4-hydroxycumarin; NSC-59813; Coumafene [French]; NCGC00094810-01; Warfarina; Warfarinum; (R)-(+)-Warfarin; Zoocoumarin [Russian]; Latka 42 [Czech]; Warfarin [INN:BAN]; DSSTox_CID_3742; 4-Idrossi-3-(3-oxo-)-fenil-butil)-cumarine; Warfarine [INN-French]; Warfarine [ISO-French]; Warfarinum [INN-Latin]; DSSTox_RID_77177; (Phenyl-1 acetyl-2 ethyl) 3-hydroxy-4 coumarin; Coumarin, 3-(.alpha.-acetonylbenzyl)-4-hydroxy-; DSSTox_GSID_23742; Warfarina [INN-Spanish]; Warfarin, analytical standard; Warfarin plus [discontinued]; Caswell No. 903; 3-(.alpha.-Phenyl-.beta.-acetylethyl)-4-hydroxycoumarin; Warfarin [BSI:ISO]; Warfarin (and salts of); Zoocoumarin [Netherlands and USSR]; CAS-81-81-2; (R)-4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one; (S)-4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one; Warfarin (INN); Choice (TN); HSDB 1786; SR-01000195154; NCGC00094810-04; EINECS 201-377-6; NSC 59813; RCRA waste no. P001; CBKinase1_000192; CBKinase1_012592; EPA Pesticide Chemical Code 086002; BRN 1293536; wafarin; delta-con; Athrombine K; Rat-alpha-way; Rat-beta-gon; Coumarin, 3-(alpha-acetonylbenzyl)-4-hydroxy-; Killgerm sewarin p; Rat and mice bait; (RS)-Warfarin; s-(-)-warfarin; 4-Hydroxy-3-(3-oxo-1-fenyl-butyl) cumarine [Dutch]; 4-Hydroxy-3-(3-oxo-1-phenyl-butyl)-cumarin [German]; 4-Idrossi-3-(3-oxo-1-fenil-butil)-cumarine [Italian]; Rattentraenke (German); Spectrum_000194; (Phenyl-1 acetyl-2 ethyl) 3-hydroxy-4 coumarine [French]; 3-(alpha-Phenyl-beta-acetylaethyl)-4-hydroxycumarin [German]; (.+/-.)-Warfarin; Spectrum2_000935; Spectrum3_000583; Spectrum4_000381; Spectrum5_001751; Rough and ready mouse mix; EC 201-377-6; Ratten-Koederrohr (German); SCHEMBL3689; CHEMBL7252; BSPBio_002026; CBDivE_002127; CBDivE_013236; KBioGR_000901; KBioSS_000674; 5-18-04-00162 (Beilstein Handbook Reference); MLS001304042; DivK1c_000444; SCHEMBL136434; SPECTRUM1500613; SPBio_000870; GTPL6853; DTXSID5023742; HMS501G06; KBio1_000444; KBio2_000674; KBio2_003242; KBio2_005810; KBio3_001526; NINDS_000444; HMS1921K07; HMS2092C20; HMS2233L10; HMS3372L19; HMS3648B15; HMS3714G21; Pharmakon1600-01500613; HY-B0687; Tox21_113185; Tox21_202182; Tox21_300531; Warfarin 1.0 mg/ml in Acetonitrile; BBL027615; BDBM50343352; CCG-39672; MFCD00272376; NSC757385; s4545; STK364490; Warfarin and salts, when present at concentration greater than 0.3%; WLN: T66 BOVJ DYR&1V1 EQ; AKOS005430103; AKOS026749956; DB00682; MCULE-1618253893; NSC-757385; Rattenstreupulver Neu Schacht (German); SB48255; SB48256; 3-(a-acetonylbenzyl)-4-hydroxycoumarin; IDI1_000444; SMP1_000316; Warfarin 100 microg/mL in Acetonitrile; NCGC00094810-02; NCGC00094810-03; NCGC00094810-05; NCGC00094810-06; NCGC00159398-03; NCGC00178855-01; NCGC00188986-01; NCGC00188986-02; NCGC00254457-01; NCGC00259731-01; 2H-1-Benzopyran-2-one, 4-hydroxy-3-(3-oxo-1-phenylbutyl)-, & salts, when present at concentrations greater than 0.3%; AC-15978; SMR000718754; SBI-0051556.P002; DB-052729; DB-052730; DL-3-(a-Acetonylbenzyl)-4-hydroxycoumarin; R-(+)-3-Acetonybenzyl)-4-hydroxycoumarin; FT-0635767; FT-0635768; Warfarin, PESTANAL(R), analytical standard; 4-Hydroxy-3- (3-oxo-1-fenyl-butyl) cumarine; 4-Hydroxy-3- (3-oxo-1-phenyl-butyl)-cumarin; 4-Idrossi-3- (3-oxo-)-fenil-butil)-cumarine; C01541; D08682; H10432; AB00052125_02; AB00876255-06; 006W854; Q407431; 4-Hydroxy-3-(3-oxo-1-phenyl-butyl)-chromen-2-one; 4-hydroxy-3-(3-oxo-1-phenyl-butyl)chromen-2-one; SR-01000195154-3; SR-01000195154-4; BRD-A24514565-001-02-2; BRD-A24514565-236-01-6; SR-01000195154-10; 3-(.alpha.-Phenyl-.beta.-acetylaethyl)-4-hydroxycumarin; 4-hydroxy-3-(3-oxo-1-phenylbutyl)-1-benzopyran-2-one; Warfarin, British Pharmacopoeia (BP) Reference Standard; Z1692482575; 4-(4-hydroxy-2-oxo-2H-3-chromenyl)-4-phenyl-2-butanone; 4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one #; Warfarin4-Hydroxy-3-(3-oxo-1-phenyl-butyl)-chromen-2-one; Warfarin, United States Pharmacopeia (USP) Reference Standard; 2-Hydroxy-3-(alpha-(2-oxopropyl)benzyl)-4H-1-benzopyran-4-one; R-(+)-4-Hydroxy-3-(3-oxo-1-phenybutyl)-2H-1-benzopyran-2-one
|
Interaction ID | 1195 |
| Target type | Molecule | |
| Target unique ID | 442530 | |
| Activity | 71 nM | |
| Binding Conditions/Buffer | 20 mM Tris-HCl, 10 mM (NH4)2SO4, 10 mM KCl |
|
| Assay | Binding isotherms for aptamer |
|
| PubMed ID | 30085205 | |
|
Interaction ID | 1196 |
| Target type | Molecule | |
| Target unique ID | 20966 | |
| Activity | 71 μM | |
| Binding Conditions/Buffer | 20 mM Tris-HCl, 10 mM (NH4)2SO4, 10 mM KCl |
|
| Assay | Binding isotherms for aptamer |
|
| PubMed ID | 30085205 | |
|
Interaction ID | 1197 |
| Target type | Molecule | |
| Target unique ID | 54678486 | |
| Activity | 1492 nM | |
| Binding Conditions/Buffer | 20 mM Tris-HCl, 10 mM (NH4)2SO4, 10 mM KCl |
|
| Assay | Binding isotherms for aptamer |
|
| PubMed ID | 30085205 | |
|
Interaction ID | 1198 |
| Target type | Molecule | |
| Target unique ID | 54680783 | |
| Activity | 3918 nM | |
| Binding Conditions/Buffer | 20 mM Tris-HCl, 10 mM (NH4)2SO4, 10 mM KCl |
|
| Assay | Binding isotherms for aptamer |
|
| PubMed ID | 30085205 | |
|
Interaction ID | 1199 |
| Target type | Molecule | |
| Target unique ID | 186907 | |
| Activity | 33 μM | |
| Binding Conditions/Buffer | 20 mM Tris-HCl, 10 mM (NH4)2SO4, 10 mM KCl |
|
| Assay | Binding isotherms for aptamer |
|
| PubMed ID | 30085205 |
| Aptamer ID | Aptamer chemistry | Sequence | Similarity |
|---|---|---|---|
| Apta_419 | DNA | ATCAGGGCTAAAGAGTGCAGAGTTACTTAG | |
| Apta_1152 | DNA | GACAAGGATAAATCCTTCAATGAAGTGGGTCACTCATCTGTGA | |
| Apta_929 | DNA | GAGTGGGATGGATAGAGAATAAGTGTGGAGTGGAAGGTGA | |
| Apta_343 | DNA | AACAGAGGGACAAACGGGGGAAGATTTGACGTCGACGAC | |
| Apta_847 | DNA | CACTAGGATCTAGGGAAAAATCTCGTAAATACTATACTCCTGAGC | |
| Apta_261 | DNA | TAAACCCCAAAACAGTGCAACTAGGTGTAGGTCCCGTGGT | |
| Apta_512 | DNA | ATAGGACGATTATCGAAAATCACCAGATTGGACCCTGGTTAACGAT | |
| Apta_580 | DNA | ATGCGGGTATATGGTGCGAGAAAACAAGGGGCATACTGGA | |
| Apta_783 | DNA | AAGGGGTTGGGTGGGTTTATACAAATTAATTAATATTGTATGGTATATTT | |
| Apta_876 | DNA | GTTGCGAAAGACAACGAATGCTTTGCCTGCCATAATTTGC | |
| Apta_946 | DNA | TACCGGGTAATATGCACACATGCTGATAGCAAGCAATGCA | |
| Apta_977 | DNA | CAATCTGCTAAAACTTAAAGCCTATTAATGAAATTGTTAAGGTGGTATCC | |
| Apta_1286 | DNA | CTATACGTATTCTAACTTGTTACGTATTGGTCTCTTATTG | |
| Apta_639 | DNA | CTAAGCACAGGGAAACCAGCTAATGAGTTAGGCCTGTCCCCCACG | |
| Apta_640 | DNA | CAATGGACCTATTCGAGTACTGAATAGAACAGTCGGCGCTCTGGG | |
| Apta_158 | DNA | CACAGGCTACGGCACGTAGAGCATCACCATGATCCTGTG | |
| Apta_347 | DNA | AAAAAAAAAAAAGTACGTTCAGGAGCAGTGCGA | |
| Apta_213 | DNA | AGGAAGGCAAAAGGAAAAAAAAAAAGGAAA | |
| Apta_330 | DNA | GCTGGGTAAATAGATGATTCCCGGC | |
| Apta_514 | DNA | ACTCAGCACGCGTGTAGGGAAAACCAACCGCCCACAAGCTGCATGCAACG |